 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Bioanalytical Aspects:
Assessing feasibility of bioanalytical method development for analysing plasma samples from pharmacokinetic studies.
 |
HT Pharmaceuticals will ensure that the bioanalytical laboratory develops a method with a calibration range that meets the dose to be used for the particular study. The amount of data captured by a study specific method with a Lower Limit of Quantitation (LLOQ) is always advantageous compared to a ‘one size fits all’ bioanalytical method approach.
 |
 |